Boston, MA, United States of America

Steven Tyler

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Steven Tyler

Introduction

Steven Tyler is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of biotechnology. With a total of 6 patents, he has made remarkable strides in developing therapies for cell proliferative diseases, particularly in cancer treatment.

Latest Patents

Among his latest patents are the Anti-ErbB3 antibodies, which are monoclonal antibodies designed to bind and inhibit the activation of the epidermal growth factor receptor-related member ErbB3/HER3. These antibodies hold promise for treating various cell proliferative diseases and disorders, including certain forms of cancer associated with the activation of ErbB3/HER3.

Career Highlights

Steven Tyler is currently associated with Aveo Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health challenges, particularly in oncology.

Collaborations

He collaborates with talented professionals in the field, including Sylvie Vincent and Kristan Meetze, to enhance the impact of his research and inventions.

Conclusion

Steven Tyler's contributions to biotechnology and his innovative patents reflect his commitment to improving healthcare outcomes. His work continues to inspire advancements in cancer treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…